Variant report
Variant | nsv982919 |
---|---|
Chromosome Location | chr11:3653349-3655641 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:3652693..3655624-chr11:3656023..3659226,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537294183 | chr11:3653391-3653392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs559100131 | chr11:3653431-3653432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577329066 | chr11:3653453-3653454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559752218 | chr11:3653467-3653468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs60378510 | chr11:3653478-3653479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541521287 | chr11:3653540-3653541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186596328 | chr11:3653559-3653560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs146404400 | chr11:3653568-3653569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148577681 | chr11:3653572-3653573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535073577 | chr11:3653681-3653682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141852734 | chr11:3653705-3653706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150603346 | chr11:3653729-3653730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7946799 | chr11:3653733-3653734 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs565097817 | chr11:3653743-3653744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532160144 | chr11:3653756-3653757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs547485408 | chr11:3653846-3653847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs76165664 | chr11:3653852-3653853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs562978772 | chr11:3653858-3653859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147896906 | chr11:3653896-3653897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs189438642 | chr11:3653903-3653904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs570057031 | chr11:3653906-3653907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181672207 | chr11:3653913-3653914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558941025 | chr11:3653914-3653915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs538449832 | chr11:3653954-3653955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs371296008 | chr11:3653982-3653983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76943051 | chr11:3653997-3653998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs375619612 | chr11:3654056-3654057 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs117672338 | chr11:3654097-3654098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553536527 | chr11:3654103-3654104 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574963198 | chr11:3654109-3654110 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114207157 | chr11:3654110-3654111 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557381845 | chr11:3654143-3654144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs370533065 | chr11:3654163-3654164 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs56410111 | chr11:3654164-3654165 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145157682 | chr11:3654167-3654168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372699924 | chr11:3654169-3654170 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs543703532 | chr11:3654172-3654173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565005029 | chr11:3654214-3654215 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs530296548 | chr11:3654236-3654237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186004589 | chr11:3654263-3654264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs559070094 | chr11:3654329-3654330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191165881 | chr11:3654359-3654360 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs183336612 | chr11:3654360-3654361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs139697608 | chr11:3654369-3654370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372442962 | chr11:3654378-3654379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530400853 | chr11:3654396-3654397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs574132069 | chr11:3654440-3654441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs34954455 | chr11:3654455-3654456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186138073 | chr11:3654459-3654460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs571038008 | chr11:3654463-3654464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 19432969 | CNVD |
Alzheimer''s disease | 17576883 | CNVD |
Long-qt syndrome | 17576883 | CNVD |
Emphysema | 19352772 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Neuroblastoma | 21124317 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Schizophrenia | 21399695 | CNVD |
Gastric cancer | 16891809 | CNVD |
Cancer | 17160897 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:3648200-3656200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
2 | chr11:3648800-3662800 | Weak transcription | Primary hematopoietic stem cells | blood |
3 | chr11:3650200-3658400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr11:3650400-3654000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr11:3650400-3655600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr11:3654000-3654400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr11:3654400-3655600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr11:3655400-3655600 | Active TSS | Gastric | stomach |
9 | chr11:3655600-3655800 | Genic enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr11:3655600-3656200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr11:3655600-3663000 | Weak transcription | Gastric | stomach |